Sanofi (OTCMKTS:SNYNF – Get Free Report) saw a significant decline in short interest during the month of April. As of April 30th, there was short interest totaling 152,194 shares, a decline of 42.6% from the April 15th total of 265,221 shares. Based on an average daily volume of 7,571 shares, the short-interest ratio is currently 20.1 days.
Sanofi Stock Performance
Shares of SNYNF opened at $85.30 on Tuesday. The company’s fifty day moving average is $90.60 and its 200 day moving average is $94.37. Sanofi has a fifty-two week low of $83.17 and a fifty-two week high of $107.24.
Sanofi Company Profile
Sanofi is a multinational biopharmaceutical company headquartered in Paris, France, specializing in the research, development and manufacturing of prescription medicines, vaccines and consumer healthcare products. With a strategic focus on specialty care, vaccines, and general medicines, Sanofi’s portfolio addresses a broad range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology and rare diseases. The company operates through distinct business segments, each dedicated to advancing patient care through innovative therapies and preventive solutions.
In its pharmaceuticals segment, Sanofi develops and markets biologics and small molecules designed to treat chronic and acute conditions.
Read More
- Five stocks we like better than Sanofi
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.
